Cholesterol and Other Cardiovascular Testing: A Global Strategic Business Report
San Jose, California (PRWEB) March 14, 2012
Follow us on LinkedIn – Cholesterol testing is gaining prominence as the basic and most important marker for assessing the risk of heart disease, the number one killer the world over. Various studies have conclusively proven the link between increased risk of cardiovascular disease (CVD) and abnormally high levels of cholesterol or lipid disorders. Health conscious adults as well as patients-at-risk are getting cholesterol levels checked more frequently than ever, prompted by increased awareness due to intense campaigning by various health organizations. Another major noticeable trend is the emergence of over-the-counter home cholesterol test kits. Technological innovations are making these kits more reliable, fast, easy to use, and cost effective, compared to laboratory testing, thus explaining the steady growth forecast in the overall Cholesterol and Other Cardiovascular Testing market. On the other hand, several new variants of cardiovascular and other tests such as homocysteine test, C-reactive protein test in the product line promise more clarity in CVD risk assessment. All this is translating to burgeoning potential for makers of cholesterol testing devices, clinics offering testing services, as well as pharmaceutical companies offering cholesterol-lowering cardiovascular drugs.
As stated by the new market research report on Cholesterol and Other Cardiovascular Testing, the global market is projected to record healthy pace in near future, with emerging economies including Asia-Pacific, Eastern Europe and Latin America likely to account for a major proportion of this growth. Asia-Pacific represents the largest market for Cholesterol and Other Cardiovascular Testing. A vast potential of population in the region remains untapped, thus promising significant growth opportunities for existing players, as well as new entrants. Segment-wise, Lipid Panel Test/Complete Lipid Profile represents the largest as well as fastest growing segment in the global cholesterol and other cardiovascular tests market. Cardiovascular, diabetics, and the relatively new nucleic acid tests are expected to grow at a faster pace when compared to the mature clinical chemistry and hematology segments.
Major players profiled in the report include AccuTech LLC, Alere Inc., Axis-Shield Plc, Biosite Inc., Beckman Coulter Inc., F. Hoffmann-La Roche Ltd., Polymer Technology Systems Inc., and Siemens Healthcare Diagnostics Inc.
The research report titled "Cholesterol and Other Cardiovascular Testing: A Global Strategic Business Report" announced by Global Industry Analysts, Inc., provides a comprehensive review of trends, issues, strategic industry activities, and profiles of major companies worldwide. The report annual unit sales estimates and projections for Cholesterol and Other Cardiovascular Testing market for the years 2007 through 2015 for the following geographic markets - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Key segments analyzed include Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests.
For more details about this comprehensive market research report, please visit –
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/